From Research Tool to Clinical Reality
The cost of sequencing a complete human genome has fallen dramatically since the original Human Genome Project, transforming whole genome sequencing from an extraordinarily expensive research endeavor into a tool increasingly used in routine clinical practice. This has opened new possibilities for diagnosing rare genetic diseases, understanding cancer at the molecular level, and informing treatment decisions based on an individual complete genetic blueprint rather than testing single genes in isolation.
Genuine Diagnostic Power
Whole genome sequencing has proven particularly valuable for diagnosing rare and previously mysterious genetic conditions, especially in critically ill infants and children where rapid diagnosis can change treatment and outcomes. It has ended prolonged diagnostic odysseys for many families by identifying causative mutations that targeted single-gene testing would have missed, and in cancer, it helps characterize the specific mutations driving an individual tumor to guide targeted therapy selection.
Current Limitations
Despite this power, whole genome sequencing has real limitations: interpreting the vast amount of data it generates remains challenging, many genetic variants have uncertain clinical significance, and the test can reveal information about conditions unrelated to the original reason for testing, raising complex questions about what to disclose. As interpretation tools and databases improve, genomic medicine continues to mature, but expert guidance remains essential to make sense of results. Research facilities can source lab supplies and diagnostic equipment from our catalog.
